{
  "trial_id": "NCT02126098",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "Males and Females",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Aged from 18-75 years with informed consent",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Patients with ANCA-vasculitis",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Wegener's granulomatosis, microscopic polyangiitis or CSS",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "positive serum assays for proteinase 3-ANCA or myeloperoxidase-ANCA",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "manifestations of activity disease, and Birmingham Vasculitis Activity Score for Wegener's Granulomatosis (BVAS/WG) of 3 or more",
      "label": "met",
      "evidence": "quote"
    }
  ],
  "exclusion": [
    {
      "criterion": "Females planning to bear a child recently or with childbearing potential",
      "label": "not_met",
      "evidence": "none"
    },
    {
      "criterion": "Secondary vasculitis, cancer,infective disease or drug induced vasculitis",
      "label": "unknown",
      "evidence": "none"
    }
  ],
  "notes": "Patient has been treating with corticosteroid and cyclophosphamides since 4 months ago. His Birmingham Vasculitis Activity Score (BVAS) is above 4.",
  "_meta": {
    "topic_id": "54",
    "trial_id": "NCT02126098",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}